Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand

Asghari, 1995, Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants, J. Neurochem., 10.1046/j.1471-4159.1995.65031157.x

Cheng, 1973, Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction, Biochem. Pharmacol., 22, 3099, 10.1016/0006-2952(73)90196-2

Farde, 1988, Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs, Arch. Gen. Psychiatry, 45, 71, 10.1001/archpsyc.1988.01800250087012

Grandy, 1989, Cloning of the cDNA and gene for a human D2 dopamine receptor, 86, 9762

Hartley, 1978, The effect of varying 3H-spiperone concentration on its binding parameters, Life Sci., 23, 513, 10.1016/0024-3205(78)90163-7

Hruska, 1984, Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand [3H]spiperone ([3H]spiroperidol), J. Neurosci. Res., 12, 571, 10.1002/jnr.490120406

Karbe, 1991, Positron emission tomography with (18F)methyl-spiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol, J. Neural Transm., 86, 163, 10.1007/BF01250702

Kawagoe, 1992, Regulation of transient dopamine concentration gradients in the microenvironment sorrounding nerve terminals in the rat striatum, Neuroscience, 51, 55, 10.1016/0306-4522(92)90470-M

Louwerens, 1993, vol. 4, 130

Malmberg, 1993, Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B and D3 receptors, Mol. Pharmacol., 43, 749

Meltzer, 1995, Plasma clozapine levels and treatment of L-DOPA-induced psychosis in Parkinson's Disease, Neuropsychopharmacology, 12, 39

Munson, 1988, An exact correction to the “Cheng-Prusoff” correction, J. Receptor Res., 8, 533, 10.3109/10799898809049010

Niznik, 1985, Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2, Naunyn-Schmiedeberg's Arch. Pharmacol., 329, 333, 10.1007/BF00496365

Ross, 1991, Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism, J. Neurochem., 56, 22, 10.1111/j.1471-4159.1991.tb02557.x

Seeman, 1992, Dopamine receptor sequences. Therapeutics levels of neuroleptics occupy D2 receptors, clozapine occupies D4, Neuropsychopharmacology, 7, 261

Seeman, 1984, Dopamine receptor parameters detected by 3H-spiperone depend on tissue concentration: analysis and examples, J. Neurochem., 43, 221, 10.1111/j.1471-4159.1984.tb06700.x

Seeman, 1992, The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography, Eur. J. Pharmacol.-Mol. Pharmacol. Sect., 277, 139, 10.1016/0922-4106(92)90121-B

Terai, 1989, Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine D-2 receptor binding to rat striatum, Eur. J. Pharmacol., 173, 177, 10.1016/0014-2999(89)90516-5

Van Tol, 1991, Cloning of the gene for a human D4 receptor with high affinity for the antipsychotic clozapine, Nature, 350, 610, 10.1038/350610a0

Watanabe, 1985, Regulation of anterior pituitary D2 dopamine receptors by magnesium and sodium ions, J. Neurochem., 45, 1842, 10.1111/j.1471-4159.1985.tb10542.x